<DOC>
	<DOCNO>NCT01754935</DOCNO>
	<brief_summary>The current study design evaluate safety efficacy , include MRI imaging , across range VX-509 dose subject active rheumatoid arthritis ( RA ) inadequate response disease-modifying antirheumatic drug ( DMARDs ) .</brief_summary>
	<brief_title>A Magnetic Resonance Imaging Study Arthroscopic Biopsy Substudy Subjects With Active Rheumatoid Arthritis Receiving VX-509 , Oral JAK3 Inhibitor</brief_title>
	<detailed_description>VX-509 oral , selective Janus kinase 3 ( JAK3 ) inhibitor develop Vertex . In autoimmune disease , JAK3 essential component immune signal cascade . This cascade ultimately contribute abnormal immune response result chronic inflammation , case rheumatoid arthritis ( RA ) , irreversible damage cartilage bone . Selective inhibition JAK3 offer new disease modify approach treatment RA , broad range autoimmune disease .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Antirheumatic Agents</mesh_term>
	<criteria>Male female subject 18 65 year age ( inclusive ) Diagnosis RA Swollen joint count ≥6 66 joint tender joint count ≥6 68 joint Seropositivity base either positive rheumatoid factor anti cyclic citrullinated peptide antibody screening OR know erosive disease base previous Xray report erosion detect screen hand foot Xray Baseline CRP level Westergren erythrocyte sedimentation rate ≥1.2 × upper limit normal Receiving stable therapy 1 follow DMARDs : methotrexate , sulfasalazine , leflunomide , antimalarial drug , penicillamine Palpable 2+ synovitis wrist ≥2 MCPs MRIdesignated hand History presence clinically significant medical disorder RA , opinion investigator medical monitor , would pose risk subject safety interfere study evaluation , procedure , completion . Inflammatory , rheumatological disorder RA , arthritis may prominent feature Planned surgery study History alcohol drug abuse , excessive alcohol consumption History tuberculosis ( TB ) infection kind ( pulmonary extrapulmonary , active latent ) , regardless history antiTB treatment . Pregnant nursing infant life partner pregnant , nursing , plan become pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>